CDx Diagnostics® provides clinicians with cost-effective tools to detect precancerous changes early using AI, computer imaging, and WATS3D cytopathology. These tests are quick, widely reimbursed, and address critical diagnostic gaps, saving lives by identifying precancerous cells missed by other methods.